PureTech Health plc (LON:PRTC – Get Free Report)’s share price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 182.14 ($2.24) and traded as high as GBX 188.91 ($2.32). PureTech Health shares last traded at GBX 182.20 ($2.24), with a volume of 274,099 shares changing hands.
PureTech Health Stock Performance
The stock has a 50-day simple moving average of GBX 181.65 and a 200-day simple moving average of GBX 203.68. The stock has a market cap of £472.60 million, a PE ratio of -1,270.00 and a beta of 0.88. The company has a debt-to-equity ratio of 25.41, a current ratio of 7.31 and a quick ratio of 2.51.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Further Reading
- Five stocks we like better than PureTech Health
- Manufacturing Stocks Investing
- 3 large caps with red hot RSIs with upside
- What is a Special Dividend?
- Johnson Controls International: Nothing but upside for investors
- 3 Monster Growth Stocks to Buy Now
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
